Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Tan

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
EMBO Molecular Medicine|April 5, 2012
P-selectin genotype is associated with the development of cancer cachexiaBenjamin H L Tan, Torill Fladvad, Theodore P Braun, et al.
Nature|February 9, 1999
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisY Y Kong, H Yoshida, I Sarosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandH Hsu, D L Lacey, C R Dunstan, et al.
Journal of Internal Medicine|January 14, 2018
The challenges and possibilities of public access defibrillationM Ringh, J Hollenberg, T Palsgaard-Moeller, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 30, 2016
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight lossNeil Johns, Cynthia Stretch, Benjamin H L Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolismJ Li, I Sarosi, X Q Yan, et al.
Cell|May 6, 1998
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationD L Lacey, E Timms, H L Tan, et al.
Cell|April 18, 1997
Osteoprotegerin: a novel secreted protein involved in the regulation of bone densityW S Simonet, D L Lacey, C R Dunstan, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 18, 2021
Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)W P Te Rijdt, E T Hoorntje, R de Brouwer, et al.
ESMO Open|September 17, 2024
Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomesR Sundar, D K A Chia, J J Zhao, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
EMBO Molecular Medicine|April 5, 2012
P-selectin genotype is associated with the development of cancer cachexiaBenjamin H L Tan, Torill Fladvad, Theodore P Braun, et al.
Nature|February 9, 1999
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisY Y Kong, H Yoshida, I Sarosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandH Hsu, D L Lacey, C R Dunstan, et al.
Journal of Internal Medicine|January 14, 2018
The challenges and possibilities of public access defibrillationM Ringh, J Hollenberg, T Palsgaard-Moeller, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 30, 2016
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight lossNeil Johns, Cynthia Stretch, Benjamin H L Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolismJ Li, I Sarosi, X Q Yan, et al.
Cell|May 6, 1998
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationD L Lacey, E Timms, H L Tan, et al.
Cell|April 18, 1997
Osteoprotegerin: a novel secreted protein involved in the regulation of bone densityW S Simonet, D L Lacey, C R Dunstan, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 18, 2021
Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)W P Te Rijdt, E T Hoorntje, R de Brouwer, et al.
ESMO Open|September 17, 2024
Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomesR Sundar, D K A Chia, J J Zhao, et al.
Pageof 20